Nordson Q2 2026: A Quiet Power Move in EPS and a Bolt-On Readiness for Precision Agriculture

Overview: A quarter of steady acceleration and disciplined positioning

Nordson posted second-quarter revenue of $741 million, up 8% year over year. The growth was broad-based, with organic growth of 7% and favorable currency translation contributing 3%. Backlog rose 18% versus the prior year, signaling durable demand for the company’s precision coating, polymer processing, and related systems. Net income reached $117 million, yielding GAAP EPS of $2.09. On an adjusted basis—excluding one-time items and acquisition-related amortization and costs—EPS was a record $2.86, up 18% from the prior year’s adjusted EPS of $2.42. EBITDA came in at $235 million, equal to 32% of sales, reflecting continued operating leverage in the core businesses.

Quarter Highlights by Segment

• Industrial Precision Solutions: Sales of $350 million, EBITDA of $124 million, or 35% of sales. The segment grew 10% year over year, supported by an organic rise of 5%, a favorable currency translation of 4%, and an acquisition-related contribution of 1%.
• Medical and Fluid Solutions: Sales of $213 million, EBITDA of $79 million (about 37% of sales). Growth was led by organic gains of 8% and a favorable currency impact of 1%, with a 4% drag from the previously divested medical contract manufacturing business offsetting some momentum.
• Advanced Technology Solutions: Sales of $178 million, EBITDA of $48 million (roughly 27% of sales). Organic growth ran around 8% with a 2% tailwind from currency.

One-Time Items and the Adjusted View

GAAP results reflect a one-time, non-cash settlement to annuitize about 30% of the U.S. pension obligation and a non-cash loss on minority investments. Excluding these items and acquisition-related amortization and costs, the second-quarter adjusted EPS was a record $2.86, up 18% from the prior year’s adjusted EPS of $2.42.

Strategy, CapstanAG, and the Path Forward

Beyond the headline numbers, Nordson’s strategic backdrop matters. The company highlighted the impact of its Ascend Strategy—focusing on high-growth, higher-margin end markets and product platforms—while continuing to invest in complementary acquisitions. Notably, Nordson closed the CapstanAG Systems deal in March 2026, a North American bolt-on designed to expand its precision agriculture portfolio with mid-tier OEMs. CapstanAG is positioned as a platform to broaden Nordson’s footprint in North America and to create cross-sell opportunities across its three segments.

Outlook: Higher Guidance and a Grip on Free Cash Flow

The press release notes an increase in full-year guidance for both sales and earnings, underscoring management’s confidence in sustained demand and the ability to translate growth into higher profitability. Free cash flow generation remains a focal point, enabling a balanced approach to shareholder returns and reinvestment in growth initiatives. While a formal EPS consensus or explicit revenue forecast beyond the raised guidance isn’t published in the release, the raised outlook and the sizable backlog imply a constructive setup for the second half of the year and potential positive read-through for sector peers in areas like precision manufacturing and industrial coatings.

Takeaways for Investors and Observers

Nordson continues to show a resilient, diversified profile across coatings, polymer processing, medical solutions, and precision technologies. The strength in Adjusted EPS—up 18% year over year to $2.86—demonstrates earnings quality beyond one-time items, even as GAAP results carry a pension-related and minority-investment drag. The CapstanAG acquisition signals a deliberate push into precision agriculture with an eye toward cross-segment synergies and a broader North American footprint. For peers, Nordson’s mix of stable end markets, disciplined margin management, and strategic bolt-ons may be a blueprint for sustaining growth in a year where aerospace, automotive, and general manufacturing demand present a mixed bag. In short, EPS momentum, a higher revenue forecast, and a strategic toolkit that includes acquisitions may keep Nordson’s stock on a steadier path—even if the background tune remains the same: capital equipment cycles, not one-off crowdfunding campaigns.

Note on market chatter: the release does not disclose a formal EPS consensus or an explicit earnings surprise figure. Still, the company’s all-in EPS trajectory and raised revenue outlook provide a narrative for analysts pondering where earnings surprises might land in the coming quarters, and where EPS consensus expectations could drift as CapstanAG and other initiatives scale.